search
Back to results

Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe (EPAZ)

Primary Purpose

HIV Infection

Status
Unknown status
Phase
Not Applicable
Locations
Zimbabwe
Study Type
Interventional
Intervention
Mother support groups for HIV+ mothers
Sponsored by
Family AIDS Caring Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for HIV Infection focused on measuring HIV/AIDS, Prevention of mother-to-child transmission, Mother support groups, Retention-in-care, Male participation, Anti-retroviral treatment, Infants

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant mothers
  • with documented HIV-1 infection attending an antenatal clinic for the current pregnancy
  • Aged 18 years of age or greater
  • Attending the clinic with no known intention at the time of enrolment to permanently migrate outside the catchment area of the clinic for the duration of the study follow-up period
  • Estimated gestational age of 34 weeks or less at time of enrolment
  • Willing to have her infant, when born, participate in the study.
  • Able and willing to give informed consent to participate

Exclusion Criteria:

  • Pregnant mothers with no documented HIV infection
  • Under 18 years of age
  • Not able or willing to give informed consent to participate
  • Estimated gestational age of over 34 weeks when considered for possible enrolment
  • Not residing in catchment area of clinic
  • Planning to relocate out of the catchment area of the clinic for the duration of study follow-up period or longer
  • Any condition that in the opinion of the investigators would interfere with adherence to study requirements. Such conditions include mental illness or active drug or alcohol use or dependence.
  • Unwilling for her infant, when born, to participate in the infant component of the study

Sites / Locations

  • Family AIDS Caring TrustRecruiting
  • Family AIDS Caring Trust

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Mother support groups for HIV+ mothers

Standard of Care Arm

Arm Description

Facility-based mother support groups (MSGs) for HIV+ mothers. MSGs were established prior to study enrolment. MSGs are facilitated by volunteer mothers. Groups meet every two weeks. Health information is provided by health workers during MSGs. Mothers receive HIV prevention, psychosocial and treatment support, reinforce safe feeding practices, promote linkages with family planning services and support disclosure by HIV+ mothers to partners, male attendance and male HIV treatment. Mothers leave MSGs 6 months postnatally. Volunteer MSG coordinators contact defaulting mothers visits using cell phones; VHWs may conduct home visits to to defaulting MSG members to reduce LTFU;

Standard of Care: Nurses may identify HIV+ mothers lost to follow-up (LTFU); village health workers (VHWs) may conduct home visits to reduce LTFU of HIV+ mothers. LTFU activities are not standardised throughout all Ministry of Health and Child Care facilities.

Outcomes

Primary Outcome Measures

One-year retention rates of HIV-exposed infants in post-natal follow-up

Secondary Outcome Measures

a. Retention rates of HIV-infected mothers

Full Information

First Posted
August 12, 2014
Last Updated
August 13, 2014
Sponsor
Family AIDS Caring Trust
Collaborators
World Health Organization, Canadian International Development Agency
search

1. Study Identification

Unique Protocol Identification Number
NCT02216734
Brief Title
Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe
Acronym
EPAZ
Official Title
Effects of Mother Support Groups on Prevention of Mother-To-Child Transmission (PMTCT) Outcomes in Mutare & Makoni Districts, Zimbabwe: A Cluster Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Unknown status
Study Start Date
July 2014 (undefined)
Primary Completion Date
November 2016 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Family AIDS Caring Trust
Collaborators
World Health Organization, Canadian International Development Agency

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators hypothesize that a strategy of establishing facility-based mother support groups (MSGs) for HIV-positive mothers will result in increased retention rates of HIV-exposed infants in clinic-based PMTCT follow-up systems twelve months post-delivery compared to clinics that lack MSGs. The study will be conducted in health facilities in rural Mutare and Makoni health districts in Manicaland province, Zimbabwe. A two-arm cluster controlled study design will be used in 30 rural clinics randomly assigned to either arm to compare the effectiveness of MSGs. Arm 1 of the study consists of standard of care whilst arm 2 consists of standard of care together with facility-based MSGs.
Detailed Description
PRIMARY OBJECTIVE To test whether MSGs lead to increased retention of HIV-exposed infants in PMTCT programmes SECONDARY OBJECTIVES To assess whether MSGs lead to increased retention of mothers in postnatal HIV follow-up care To assess whether male participation in PMTCT activities is increased at clinics with MSGs To assess whether selected maternal and infant health indicators are improved in HIV-positive mothers and their exposed infants at facilities with MSGs, viz. (1) Antenatal attendance; (2) Delivery in facilities; (3) Infant immunisation uptake; (4) Infant feeding methods and nutrition status; (5) Infant nevirapine prophylaxis; (6) Infant co-trimoxazole prophylaxis; (7) Infant HIV testing; and (8) Family planning uptake MOTHER SUPPORT GROUP INTERVENTION MSGs were designed following formative research. A non-governmental organisation established MSGs by recruiting HIV+ mothers and volunteer coordinators (MSGCs) prior to commencing enrolment. MSGCs were HIV-positive mothers who were trained in MSG establishment and maintenance, retention activities and data collection. MSGs meet each two weeks with the MSGC or health worker facilitating an information session using a curriculum of eight PMTCT-related topics. MSGCs send standard message reminders to members, contact non-attending members by phone and inform health workers (HWs) to assist retention. HWs conduct retention actions of non-attending patients in PMTCT programmes. SAMPLE SIZE AND RANDOMISATION We excluded from the study low-volume facilities that recorded booking fewer than 10 HIV-positive antenatal mothers per annum. We randomly selected facilities in the two study districts to either of the study arms. Based on estimated infant retention rates for control and intervention arms, we calculated the minimum sample size of 10 HIV-positive mothers to be enrolled at each health facility. DATA COLLECTION, ANALYSIS AND QUALITY ASSURANCE The study utilizes the existing health information system (e.g. antenatal care (ANC) Register, Exposed Infant Follow-Up Register, Anti-retroviral treatment (ART) Register), supplemented by EPAZ study-related data collection and patient tracking systems. Study staff will work with clinic- and district-level staff to improve and collect routine and study-specific data. Data will be entered, coded, cleaned and locked before analyses are made. Data will be analysed on an intention-to-treat basis. A mobile team of well-trained quality assurance and control study staff will be deployed throughout the data collection period to ensure quality of the intervention and of data generated and collected at each study site. A pre-specified proportion of patient visit records will be reviewed from each site.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infection
Keywords
HIV/AIDS, Prevention of mother-to-child transmission, Mother support groups, Retention-in-care, Male participation, Anti-retroviral treatment, Infants

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mother support groups for HIV+ mothers
Arm Type
Experimental
Arm Description
Facility-based mother support groups (MSGs) for HIV+ mothers. MSGs were established prior to study enrolment. MSGs are facilitated by volunteer mothers. Groups meet every two weeks. Health information is provided by health workers during MSGs. Mothers receive HIV prevention, psychosocial and treatment support, reinforce safe feeding practices, promote linkages with family planning services and support disclosure by HIV+ mothers to partners, male attendance and male HIV treatment. Mothers leave MSGs 6 months postnatally. Volunteer MSG coordinators contact defaulting mothers visits using cell phones; VHWs may conduct home visits to to defaulting MSG members to reduce LTFU;
Arm Title
Standard of Care Arm
Arm Type
No Intervention
Arm Description
Standard of Care: Nurses may identify HIV+ mothers lost to follow-up (LTFU); village health workers (VHWs) may conduct home visits to reduce LTFU of HIV+ mothers. LTFU activities are not standardised throughout all Ministry of Health and Child Care facilities.
Intervention Type
Behavioral
Intervention Name(s)
Mother support groups for HIV+ mothers
Intervention Description
Facility-based mother support groups (MSGs) for HIV+ mothers. MSGs were established prior to study enrolment. MSGs are facilitated by volunteer mothers. Groups meet every two weeks. Health information is provided by health workers during MSGs. Mothers receive HIV prevention, psychosocial and treatment support, reinforce safe feeding practices, promote linkages with family planning services and support disclosure by HIV+ mothers to partners, male attendance and male HIV treatment. Mothers leave MSGs 6 months postnatally. Volunteer MSG coordinators contact defaulting mothers visits using cell phones; VHWs may conduct home visits to to defaulting MSG members to reduce LTFU;
Primary Outcome Measure Information:
Title
One-year retention rates of HIV-exposed infants in post-natal follow-up
Time Frame
12 months postnatal
Secondary Outcome Measure Information:
Title
a. Retention rates of HIV-infected mothers
Time Frame
12 months postnatal

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant mothers with documented HIV-1 infection attending an antenatal clinic for the current pregnancy Aged 18 years of age or greater Attending the clinic with no known intention at the time of enrolment to permanently migrate outside the catchment area of the clinic for the duration of the study follow-up period Estimated gestational age of 34 weeks or less at time of enrolment Willing to have her infant, when born, participate in the study. Able and willing to give informed consent to participate Exclusion Criteria: Pregnant mothers with no documented HIV infection Under 18 years of age Not able or willing to give informed consent to participate Estimated gestational age of over 34 weeks when considered for possible enrolment Not residing in catchment area of clinic Planning to relocate out of the catchment area of the clinic for the duration of study follow-up period or longer Any condition that in the opinion of the investigators would interfere with adherence to study requirements. Such conditions include mental illness or active drug or alcohol use or dependence. Unwilling for her infant, when born, to participate in the infant component of the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Geoff Foster, MB BS MRCP
Phone
+263772265830
Email
geofffoster53@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geoff Foster, MB BS MRCP
Organizational Affiliation
Ministry of Health and Child Welfare, Zimbabwe
Official's Role
Principal Investigator
Facility Information:
Facility Name
Family AIDS Caring Trust
City
Mutare
State/Province
Manicaland
Country
Zimbabwe
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vhumani Magezi
Phone
+2632061648
Email
vhumani@hotmail.com
Facility Name
Family AIDS Caring Trust
City
Mutare
State/Province
Manicaland
Country
Zimbabwe
Individual Site Status
Enrolling by invitation

12. IPD Sharing Statement

Citations:
PubMed Identifier
28498193
Citation
Cataldo F, Sam-Agudu NA, Phiri S, Shumba B, Cornelius LJ, Foster G. The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S224-S232. doi: 10.1097/QAI.0000000000001375.
Results Reference
derived
PubMed Identifier
28498191
Citation
Foster G, Orne-Gliemann J, Font H, Kangwende A, Magezi V, Sengai T, Rusakaniko S, Shumba B, Zambezi P, Maphosa T. Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S207-S215. doi: 10.1097/QAI.0000000000001360.
Results Reference
derived
PubMed Identifier
25310121
Citation
Foster G, Kangwende A, Magezi V, Maphosa T, Mashapa R, Mukora-Mutseyekwa F, Mushavi A, Rusakaniko S, Shumba B, Zambezi P. Cluster randomized trial on the effect of mother support groups on retention-in-care and PMTCT outcomes in Zimbabwe: study design, challenges, and national relevance. J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S145-9. doi: 10.1097/QAI.0000000000000325.
Results Reference
derived

Learn more about this trial

Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe

We'll reach out to this number within 24 hrs